Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca(2+) overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection

Circ Res. 2001 Nov 9;89(10):891-8. doi: 10.1161/hh2201.100205.

Abstract

Mitochondrial ATP-sensitive potassium (mitoK(ATP)) channels play a key role in ischemic preconditioning of the heart. However, the mechanism of cardioprotection remains controversial. We measured rhod-2 fluorescence in adult rabbit ventricular cardiomyocytes as an index of mitochondrial matrix Ca(2+) concentration ([Ca(2+)](m)), using time-lapse confocal microscopy. To simulate ischemia and reperfusion (I/R), cells were exposed to metabolic inhibition (50 minutes) followed by washout with control solution. Rhod-2 fluorescence gradually increased during simulated ischemia and rose even further with reperfusion. The mitoK(ATP) channel opener diazoxide attenuated the accumulation of [Ca(2+)](m) during simulated I/R (EC(50)=18 micromol/L). These effects of diazoxide were blocked by the mitoK(ATP) channel antagonist 5-hydroxydecanoate (5HD). In contrast, inhibitors of the mitochondrial permeability transition (MPT), cyclosporin A and bongkrekic acid, did not alter [Ca(2+)](m) accumulation during ischemia, but markedly suppressed the surge in rhod-2 fluorescence during reperfusion. Measurements of mitochondrial membrane potential, DeltaPsi(m), in permeabilized myocytes revealed that diazoxide depolarized DeltaPsi(m) (by 12% at 10 micromol/L, P<0.01) in a 5HD-inhibitable manner. Our data support the hypothesis that attenuation of mitochondrial Ca(2+) overload, as a consequence of partial mitochondrial membrane depolarization by mitoK(ATP) channels, underlies cardioprotection. Furthermore, mitoK(ATP) channels and the MPT differentially affect mitochondrial calcium homeostasis: mitoK(ATP) channels suppress calcium accumulation during I/R, while the MPT comes into play only upon reperfusion.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Bongkrekic Acid / pharmacology
  • Calcium / metabolism*
  • Cell Separation
  • Cytoprotection
  • Decanoic Acids / pharmacology
  • Diazoxide / pharmacology
  • Dose-Response Relationship, Drug
  • Fluorescent Dyes
  • Heterocyclic Compounds, 3-Ring
  • Hydroxy Acids / pharmacology
  • In Vitro Techniques
  • Intracellular Membranes / metabolism
  • Ischemic Preconditioning*
  • Membrane Proteins / drug effects
  • Membrane Proteins / metabolism*
  • Microscopy, Confocal
  • Microscopy, Fluorescence
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Myocardial Ischemia / metabolism*
  • Myocardial Reperfusion
  • Myocardium / cytology
  • Myocardium / metabolism*
  • Permeability / drug effects
  • Potassium Channels / drug effects
  • Potassium Channels / metabolism

Substances

  • Decanoic Acids
  • Fluorescent Dyes
  • Heterocyclic Compounds, 3-Ring
  • Hydroxy Acids
  • Membrane Proteins
  • Potassium Channels
  • mitochondrial K(ATP) channel
  • rhod-2
  • Bongkrekic Acid
  • 5-hydroxydecanoic acid
  • Diazoxide
  • Calcium